Helix Biopharma Corp. (HBP) Set to Announce Earnings on Monday
Shares of Helix Biopharma Corp. (TSE:HBP) opened at 0.84 on Monday. The stock’s market capitalization is $78.28 million. Helix Biopharma Corp. has a 12-month low of $0.50 and a 12-month high of $1.65. The stock has a 50 day moving average of $0.89 and a 200 day moving average of $0.93.
TRADEMARK VIOLATION WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/10/23/helix-biopharma-corp-hbp-set-to-announce-earnings-on-monday.html.
About Helix Biopharma Corp.
Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company’s product development initiatives are focused primarily on technologies that modulate the tumor microenvironment.
Receive News & Ratings for Helix Biopharma Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix Biopharma Corp. and related companies with MarketBeat.com's FREE daily email newsletter.